Article and Video CATEGORIES
For our 8th video in the GRACE Spanish Lung Cancer Library, Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish speaking patients and caregivers, in this video Dr. Hunis reviews the risk factors for lung cancer.
TRANSCRIPTS - Spanish and English
Factores de riesgo del cáncer de pulmón
El riesgo de cancer de pulmón aumenta con el consumo de tabaco. La mayoría de los casos de cancer de pulmón están relacionados al consumo excesivo de tabaco y en pacientes con enfermedad pulmonar crónica.
También existe el riesgo ambiental relacionado al gas radón, que es un gas natural que ocurre en la tierra, además de otras sustancias como el smog y polución ambiental. Por supuesto que existen canceres de pulmón en pacientes que nunca han fumado y también en pacientes que han estado expuestos a tabaco en la familia por exposición a segunda mano También pacientes que han estado expuestos a asbestos, desarrollan asbestosis y con esta tienen un riesgo aumentado de desarrollar cancer de pulmón además de otro tipo de cancer llamado el mesotelioma pleural.
Risk factors for lung cancer
The risk for lung cancer increases with tobacco consumption. Most lung cancer cases are related to excessive use of tobacco and pulmonary chronic disease.
As well, there is an environmental risk that is related with radon gas, which is a natural gas from the earth, and also smog and environmental pollution. There are some lung cancer cases in patients who have never smoked and in patients who have only being secondarily exposed to tobacco with their families. Also, there are patients that have being exposed to asbestos developing asbestosis which increases the risk for lung cancer and of pleural mesothelioma.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…